Cabenuva is a Kit in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is .
| Product ID | 49702-253_0eb2c285-5f70-408e-b710-10888edb2c4e |
| NDC | 49702-253 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cabenuva |
| Generic Name | Cabotegravir And Rilpivirine |
| Dosage Form | Kit |
| Marketing Start Date | 2021-01-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212888 |
| Labeler Name | ViiV Healthcare Company |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-01-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49702-240 | Cabenuva | cabotegravir and rilpivirine |
| 49702-253 | Cabenuva | cabotegravir and rilpivirine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CABENUVA 87420884 5335232 Live/Registered |
ViiV Healthcare UK (No.3) Limited 2017-04-21 |